Company intelligence / Profile preview

Perceptive Credit Holdings II

New York, NY, USA

Ownership: Private
Development stage: Other

Overview

Perceptive Credit Holdings II provides minimally-dilutive flexible debt financing to innovative healthcare and life sciences companies, targeting biopharma, medical devices, diagnostics, and digital health across all company stages; portfolio includes direct investments in biotech/pharma companies with both preclinical and commercial programs.

Modalities: small moleculesbiologicsgene therapymedical devicesdiagnostics
Industry: Investors

Partnerships

Investment partnerships with portfolio companiesArcherDx (now acquired by Invitae)LianBio (with BridgeBio Pharma, MyoKardia, QED Therapeutics, Navire Pharma)

Beyond the preview

Go deeper on Perceptive Credit Holdings II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perceptive Credit Holdings II.

Explore the full profile